Companies: 10,795·Total market cap: $144.5T
Jounce Therapeutics, Inc.

Jounce Therapeutics, Inc.

JNCENASDAQHealthcare
$1.88
+$0.00(+0.00%)
Market Cap$98954740
P/E Ratio
52W High$5.37
52W Low$0.5773
Overview

Jounce Therapeutics, Inc. (JNCE) Stock Splits

No forward or reverse splits on record since IPO — details below.

FMP · JNCE · as of May 3, 2023

Key split metrics

Jounce Therapeutics, Inc. (JNCE) has been publicly traded since Jan 26, 2017 with no forward or reverse splits on record.

About stock split history

Jounce Therapeutics, Inc. (JNCE) has never undergone a stock split since going public.

Frequently asked questions

Jounce Therapeutics, Inc. (JNCE) has never split its stock since going public.

JNCE stock split historyhas JNCE ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.